#METABOLOMICS WORKBENCH chiharu_20191222_200500 DATATRACK_ID:1882 STUDY_ID:ST001301 ANALYSIS_ID:AN002167 PROJECT_ID:PR000882
VERSION             	1
CREATED_ON             	January 8, 2020, 11:32 am
#PROJECT
PR:PROJECT_TITLE                 	Luminal metabolome profiles of human microbiota-associated (HMA) mice treated
PR:PROJECT_TITLE                 	with anti-IL-22 antibody or control antibody
PR:PROJECT_SUMMARY               	We found that healthy (HC)-HMA mice, GF mice were colonized with gut microbiota
PR:PROJECT_SUMMARY               	derived from human HC, were protected from Clostridioides difficile (C.
PR:PROJECT_SUMMARY               	difficile) infection. However, the colonization resistance of HC-HMA mice was
PR:PROJECT_SUMMARY               	abolished by treatment of anti-IL-22 antibody, unlike control antibody-treated
PR:PROJECT_SUMMARY               	HC-HMA mice. Additionally, the gut microbial composition of anti-IL22
PR:PROJECT_SUMMARY               	antibody-treated HC-HMA mice, C. difficile-susceptible mice, were differ from
PR:PROJECT_SUMMARY               	that of control antibody, thereby it appears that luminal metabolome is changed
PR:PROJECT_SUMMARY               	between 2 groups. To examine the change in the luminal metabolites, fecal
PR:PROJECT_SUMMARY               	samples were collected from anti-IL-22 /control -antibody treated HC-HMA mice,
PR:PROJECT_SUMMARY               	and metabolite profiles of them were analyzed.
PR:INSTITUTE                     	University of Michigan
PR:DEPARTMENT                    	Internal Medicine
PR:LAST_NAME                     	Kamada
PR:FIRST_NAME                    	Nobuhiko
PR:ADDRESS                       	1150 W Medical center Dr, Ann Arbor, MI 48109, USA
PR:EMAIL                         	nkamada@umich.edu
PR:PHONE                         	+1-734-763-2142
#STUDY
ST:STUDY_TITLE                   	Luminal metabolome profiles of human microbiota-associated (HMA) mice treated
ST:STUDY_TITLE                   	with anti-IL-22 antibody or control antibody
ST:STUDY_SUMMARY                 	Luminal (fecal) metabolome of anti-IL-22 antibody-treated HMA mice and control
ST:STUDY_SUMMARY                 	antibody-treated HMA mice were compared.
ST:INSTITUTE                     	University of Michigan
ST:DEPARTMENT                    	Internal Medicine
ST:LAST_NAME                     	Kamada
ST:FIRST_NAME                    	Nobuhiko
ST:ADDRESS                       	1150 W Medical center Dr, Ann Arbor, MI 48109, USA
ST:EMAIL                         	nkamada@umich.edu
ST:PHONE                         	+1-734-763-2142
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	Ab1	Factor:Control antibody	RAW_FILE_NAME=Ab1.d
SUBJECT_SAMPLE_FACTORS           	-	Ab2	Factor:Control antibody	RAW_FILE_NAME=Ab2.d
SUBJECT_SAMPLE_FACTORS           	-	Ab3	Factor:Control antibody	RAW_FILE_NAME=Ab3.d
SUBJECT_SAMPLE_FACTORS           	-	HC-HMA-Rag1KO+Ctrl Ab #6	Factor:Control antibody	RAW_FILE_NAME=HC-HMA-Rag1KO+Ctrl Ab #6.d
SUBJECT_SAMPLE_FACTORS           	-	HC-HMA-Rag1KO+Ctrl Ab #7	Factor:Control antibody	RAW_FILE_NAME=HC-HMA-Rag1KO+Ctrl Ab #7.d
SUBJECT_SAMPLE_FACTORS           	-	HC-HMA-Rag1KO+Ctrl Ab #8	Factor:Control antibody	RAW_FILE_NAME=HC-HMA-Rag1KO+Ctrl Ab #8.d
SUBJECT_SAMPLE_FACTORS           	-	HC-HMA-Rag1KO+Ctrl Ab #9	Factor:Control antibody	RAW_FILE_NAME=HC-HMA-Rag1KO+Ctrl Ab #9.d
SUBJECT_SAMPLE_FACTORS           	-	HC-HMA-Rag1KO+Ctrl Ab #10	Factor:Control antibody	RAW_FILE_NAME=HC-HMA-Rag1KO+Ctrl Ab #10.d
SUBJECT_SAMPLE_FACTORS           	-	HC-Rag1KO+Ctrl Ab #6	Factor:Control antibody	RAW_FILE_NAME=HC-Rag1KO+Ctrl Ab #6.d
SUBJECT_SAMPLE_FACTORS           	-	HC-Rag1KO+Ctrl Ab #7	Factor:Control antibody	RAW_FILE_NAME=HC-Rag1KO+Ctrl Ab #7.d
SUBJECT_SAMPLE_FACTORS           	-	HC-Rag1KO+Ctrl Ab #8	Factor:Control antibody	RAW_FILE_NAME=HC-Rag1KO+Ctrl Ab #8.d
SUBJECT_SAMPLE_FACTORS           	-	HC-Rag1KO+Ctrl Ab #9	Factor:Control antibody	RAW_FILE_NAME=HC-Rag1KO+Ctrl Ab #9.d
SUBJECT_SAMPLE_FACTORS           	-	HC-Rag1KO+Ctrl Ab #10	Factor:Control antibody	RAW_FILE_NAME=HC-Rag1KO+Ctrl Ab #10.d
SUBJECT_SAMPLE_FACTORS           	-	Ab4	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=Ab4.d
SUBJECT_SAMPLE_FACTORS           	-	Ab5	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=Ab5.d
SUBJECT_SAMPLE_FACTORS           	-	Ab6	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=Ab6.d
SUBJECT_SAMPLE_FACTORS           	-	HC-HMA-Rag1KO+aIL-22 Ab #11	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=HC-HMA-Rag1KO+aIL-22 Ab #11.d
SUBJECT_SAMPLE_FACTORS           	-	HC-HMA-Rag1KO+aIL-22 Ab #12	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=HC-HMA-Rag1KO+aIL-22 Ab #12.d
SUBJECT_SAMPLE_FACTORS           	-	HC-HMA-Rag1KO+aIL-22 Ab #13	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=HC-HMA-Rag1KO+aIL-22 Ab #13.d
SUBJECT_SAMPLE_FACTORS           	-	HC-HMA-Rag1KO+aIL-22 Ab #14	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=HC-HMA-Rag1KO+aIL-22 Ab #14.d
SUBJECT_SAMPLE_FACTORS           	-	HC-HMA-Rag1KO+aIL-22 Ab #15	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=HC-HMA-Rag1KO+aIL-22 Ab #15.d
SUBJECT_SAMPLE_FACTORS           	-	HC-Rag1KO+aIL-22l Ab #11	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=HC-Rag1KO+aIL-22l Ab #11.d
SUBJECT_SAMPLE_FACTORS           	-	HC-Rag1KO+aIL-22l Ab #12	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=HC-Rag1KO+aIL-22l Ab #12.d
SUBJECT_SAMPLE_FACTORS           	-	HC-Rag1KO+aIL-22l Ab #13	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=HC-Rag1KO+aIL-22l Ab #13.d
SUBJECT_SAMPLE_FACTORS           	-	HC-Rag1KO+aIL-22l Ab #14	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=HC-Rag1KO+aIL-22l Ab #14.d
SUBJECT_SAMPLE_FACTORS           	-	HC-Rag1KO+aIL-22l Ab #15	Factor:Anti-IL-22 antibody	RAW_FILE_NAME=HC-Rag1KO+aIL-22l Ab #15.d
#COLLECTION
CO:COLLECTION_SUMMARY            	Feces of anti-IL-22 antibody/control antibody-treated HC-HMA mice were
CO:COLLECTION_SUMMARY            	harvested.
CO:SAMPLE_TYPE                   	Feces
#TREATMENT
TR:TREATMENT_SUMMARY             	GF C57BL/6 mice were colonized with HC microbiotas for 2 weeks. After
TR:TREATMENT_SUMMARY             	colonization of HC microbiota, the mice were treated with control or anti-IL-22
TR:TREATMENT_SUMMARY             	antibody twice (day -5 and day -3) before collecting fecal samples.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Fecal samples were lyophilized using a VD-800R lyophilizer (TAITEC) for 24
SP:SAMPLEPREP_SUMMARY            	hours. Freeze-dried feces were disrupted with 3.0-mm Zirconia Beads (Biomedical
SP:SAMPLEPREP_SUMMARY            	Science) by vigorous shaking (1,500 rpm for 10 min) using Shake Master
SP:SAMPLEPREP_SUMMARY            	(Biomedical Science). Fecal metabolites were extracted using the
SP:SAMPLEPREP_SUMMARY            	methanol:chloroform:water extraction protocol.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Other
CH:INSTRUMENT_NAME               	Agilent 7100 CE
CH:COLUMN_NAME                   	COSMO(+), i.d.50 µm(anion
CH:INTERNAL_STANDARD             	20 μM of D-camphor-10-sulfonic acid (CSA)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent G3250AA LC/MSD TOF system
MS:INSTRUMENT_TYPE               	Other
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	In-house software (MasterHands) was used for peak area integration and
MS:MS_COMMENTS                   	annotation.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	nmol/g
MS_METABOLITE_DATA_START
Samples	Ab1	Ab2	Ab3	HC-HMA-Rag1KO+Ctrl Ab #6	HC-HMA-Rag1KO+Ctrl Ab #7	HC-HMA-Rag1KO+Ctrl Ab #8	HC-HMA-Rag1KO+Ctrl Ab #9	HC-HMA-Rag1KO+Ctrl Ab #10	HC-Rag1KO+Ctrl Ab #6	HC-Rag1KO+Ctrl Ab #7	HC-Rag1KO+Ctrl Ab #8	HC-Rag1KO+Ctrl Ab #9	HC-Rag1KO+Ctrl Ab #10	Ab4	Ab5	Ab6	HC-HMA-Rag1KO+aIL-22 Ab #11	HC-HMA-Rag1KO+aIL-22 Ab #12	HC-HMA-Rag1KO+aIL-22 Ab #13	HC-HMA-Rag1KO+aIL-22 Ab #14	HC-HMA-Rag1KO+aIL-22 Ab #15	HC-Rag1KO+aIL-22l Ab #11	HC-Rag1KO+aIL-22l Ab #12	HC-Rag1KO+aIL-22l Ab #13	HC-Rag1KO+aIL-22l Ab #14	HC-Rag1KO+aIL-22l Ab #15
Factors	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Control antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody	Factor:Anti-IL-22 antibody
Acetyl CoA	44	23	30	31	60	43	48	34	12	15	21	10	34	21	16	18	18	35	34	49	48	3.3	38	49	50	72
Adipate	0	0	0	22	18	19	17	49	0	0	28	0	0	0	0	0	33	24	15	48	20	45	0	48	0	0
ADP-ribose	0	0	0	20	20	28	24	19	12	11	10	11	14	0	0	0	22	27	20	31	29	0	0	11	9.2	13
AMP	82	57	56	75	89	76	69	60	46	62	62	60	67	56	72	55	83	73	100	102	78	82	62	65	63	76
Argininosuccinate	0	0	0	6.7	0	0	0	11	5.5	10	10	7.1	11	0	0	0	16	0	0	9.4	0	23	8.4	8.5	7.0	11
Azelate	63	77	51	70	83	75	86	78	64	90	81	84	57	72	58	65	62	74	38	89	40	89	136	140	98	150
Butyrate	925	969	169	3068	4604	4693	2311	1679	1735	2081	3252	2317	2263	1433	1888	1414	5014	2609	2651	6168	4522	9821	4246	5301	6536	6932
Cholate	259	223	144	135	58	133	98	70	717	494	2026	594	403	63	87	154	119	51	646	221	92	485	214	285	242	407
cis-Aconitate	0	0	0	2.0	3.3	2.9	0	4.8	0	46	60	7.7	8.9	0	0	0	38	2.3	2.2	2.6	6.1	198	0	0	0	0
Citraconate	4.5	3.9	6.0	3.5	3.7	4.2	5.1	9.6	3.7	8.3	5.5	7.7	3.3	6.9	3.8	5.2	6.3	3.7	3.2	7.0	4.8	21	4.7	3.7	1.8	3.6
Citramalate	14	12	0	14	14	13	23	23	36	63	53	57	16	20	14	23	19	13	11	25	12	62	34	29	26	27
Citrate	76	73	111	72	63	57	36	44	41	1859	2361	197	936	41	104	79	396	38	23	115	155	7101	222	71	78	86
CMP	13	9.4	8.4	11	10	10	12	14	7.1	9.9	16	14	10	11	11	6.7	11	11	13	11	12	39	14	16	17	17
Cysteate	77	65	48	92	102	91	104	67	17	15	17	43	15	101	138	62	9.8	11	12	10	14	17	22	24	29	24
DCA	0	0	0	0	8.3	0	0	0	0	0	0	303	0	25	37	20	0	56	76	12	30	57	42	78	53	114
Dodecanedioate	12	17	9.7	12	9.7	14	15	11	20	34	32	32	15	5.2	8.7	9.5	12	9.9	5.7	15	7.8	32	37	19	20	49
dTMP	22	19	24	19	20	18	27	19	13	17	21	15	13	28	30	21	14	16	14	14	11	14	14	22	18	26
F6P	54	60	61	23	16	25	15	32	15	14	10	11	32	47	64	59	13	19	23	29	16	0	33	21	36	29
Fumarate	0	0	0	0	0	0	0	11	20	31	11	52	23	0	0	0	34	0	0	0	0	110	51	35	19	24
G1P	52	56	62	18	11	11	16	19	15	27	20	26	30	23	34	42	8.1	11	15	28	11	27	36	20	48	42
G6P	249	317	267	118	97	111	94	143	48	66	43	43	97	200	254	257	54	91	114	165	83	49	126	87	131	109
Glutarate	167	140	121	253	230	293	254	380	134	279	265	108	193	442	186	223	373	187	202	845	399	495	308	838	195	469
Glycerate	304	148	358	0	0	0	0	118	0	176	0	0	0	112	124	114	205	0	63	76	0	1438	499	0	0	0
Glycolate	352	352	304	316	264	300	162	198	0	472	330	357	266	275	299	459	352	260	133	208	180	746	517	202	212	491
Isethionate	103	62	41	51	46	73	44	194	0	123	200	18	0	0	0	0	27	0	8.5	7.2	8.4	224	0	0	0	0
Isocitrate	0	0	0	0	0	0	0	0	0	72	126	12	12	0	0	0	25	0	0	7.0	7.4	217	0	0	0	0
Lactate	1018	1134	927	4932	2132	1295	1665	2899	3068	5173	600	23196	901	790	1063	911	1019	438	166	2181	1903	2393	1411	325	295	371
Malate	121	144	109	88	92	88	100	146	95	181	110	122	293	128	94	172	189	85	71	103	139	456	251	172	145	118
Malonate	0	0	0	233	269	274	267	390	473	637	464	519	366	279	188	382	202	59	81	383	260	724	818	675	608	1129
N-Acetylaspartate	51	43	43	107	330	159	99	359	88	155	179	100	86	59	75	35	307	658	360	411	283	190	126	168	120	175
N-Acetylglucosamine 1-phosphate	47	38	40	31	32	33	30	25	30	40	47	31	25	25	35	31	20	26	44	41	27	88	36	29	30	39
N-Acetylglucosamine 6-phosphate	88	72	73	27	31	26	29	31	30	43	43	29	36	43	55	23	20	23	20	33	19	34	46	35	36	44
N-Acetylglutamate	142	82	118	271	212	199	296	263	85	139	138	145	76	64	82	57	266	259	238	464	279	304	276	542	289	399
NAD+	373	270	337	414	821	549	522	365	148	217	291	185	414	436	492	166	485	482	522	828	568	76	364	669	575	732
NADP+	19	15	13	28	41	30	31	20	9.6	13	16	10	17	18	23	9.1	27	30	27	40	25	0	25	24	28	36
Nicotinate	298	263	148	122	84	123	114	98	136	225	91	65	197	182	239	186	313	105	102	58	81	127	420	202	313	194
O-Phosphoserine	12	6.4	20	10	15	12	12	12	0	22	17	9.3	13	9.1	13	6.0	8.6	9.1	4.9	11	6.2	8.6	16	17	18	23
Pentanoate	71	72	36	229	256	158	106	92	155	163	226	149	164	136	150	125	202	190	56	195	73	137	266	460	355	545
Phenaceturate	0	0	0	0	0	0	0	0	0	141	262	23	0	0	0	0	27	0	0	0	0	270	0	0	0	0
Phthalate	5.1	4.7	2.0	6.1	5.7	5.8	5.6	6.0	3.2	3.9	3.0	3.6	2.6	4.2	2.8	3.2	5.7	5.8	4.4	7.2	5.0	3.3	3.5	3.6	2.7	3.9
Pimelate	16	13	8.9	27	23	30	26	21	14	27	26	13	19	24	22	15	23	26	13	25	16	42	27	36	23	30
Proline betaine	5.0	8.3	8.3	2.5	2.5	3.5	1.3	14	2.6	128	89	11	44	5.7	12	6.7	23	2.1	1.6	8.0	3.1	191	9.4	4.6	5.2	4.2
Propionate	6364	5528	1899	7419	7317	6445	5797	7024	9881	15355	18603	23281	11774	6228	6606	4778	7621	5532	3752	9707	3198	26691	20005	22160	13948	29508
Ru5P	51	70	61	44	26	35	30	21	0	0	0	7.4	22	27	65	41	12	26	19	22	17	0	26	19	31	24
S7P	68	65	58	52	46	42	49	51	33	46	31	42	49	53	49	35	16	32	26	39	33	0	94	62	84	90
Sebacate	10	17	7.2	6.7	8.1	8.2	9.4	6.8	9.5	13	12	13	7.2	7.3	7.4	8.1	7.2	7.4	4.8	9.6	4.2	12	16	13	11	24
Succinate	602	349	245	624	616	639	691	969	804	2217	3114	3629	671	1513	1108	1273	1918	720	502	2558	716	24309	1828	3816	1002	4598
Taurocholate	320	232	105	281	161	433	186	230	161	149	626	265	85	16	23	27	42	29	85	45	69	243	130	71	84	131
UDP	22	15	15	21	24	20	18	17	8.7	17	21	15	25	20	30	22	17	25	20	33	14	0	24	26	27	37
UMP	41	20	19	33	35	39	34	47	37	46	60	55	43	26	30	14	30	35	47	31	32	83	41	41	44	43
Urate	54	47	91	44	68	43	50	46	82	101	57	50	48	22	32	36	49	30	30	38	33	23	82	26	32	32
2,5-Dihydroxybenzoate	15	34	17	28	30	29	32	23	18	40	29	22	19	0	14	31	22	19	15	38	24	53	48	26	33	52
2-Hydroxybutyrate	0	0	0	11	0	0	0	23	0	12	0	35	0	0	0	0	13	7.8	12	28	16	35	34	29	0	28
2-Hydroxyglutarate	207	167	239	111	151	122	128	152	200	396	569	128	241	142	122	165	247	82	68	104	62	1461	291	176	209	176
2-Isopropylmalate	0	0	0	3.6	2.5	4.8	3.3	4.2	6.1	9.9	8.5	5.7	4.4	0	0	0	4.5	2.0	4.0	30	4.0	12	15	4.6	6.2	13
2-Oxoglutarate	0	0	0	78	115	123	96	136	0	0	0	0	0	0	0	0	83	100	70	87	81	0	0	0	0	0
3-(4-Hydroxyphenyl)propionate	0	0	0	651	802	953	842	521	719	1135	1058	996	669	0	0	0	921	445	620	1130	701	2217	1501	1087	1384	2235
3-Methylbutanoate	176	168	38	151	281	178	84	78	116	139	210	135	196	185	306	86	208	235	111	185	101	284	174	161	158	129
3PG	78	83	155	18	19	18	13	27	18	45	18	12	27	45	48	42	13	12	8.0	24	19	26	57	34	41	33
3-Ureidopropionate	0	0	0	0	0	0	0	0	0	177	147	0	0	0	0	0	39	0	0	0	0	408	0	0	0	0
4-Acetylbutyrate	0	0	0	9.5	8.7	9.7	7.9	7.7	19	13	14	0	17	0	0	0	8.5	8.6	7.7	13	8.1	17	0	14	9.5	0
5-Oxoproline	80	98	73	64	76	60	59	59	31	45	41	63	159	82	80	65	66	55	63	57	53	100	56	44	64	48
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	RefMet name	Formula	Mass	REGNO	KEGG ID	quantitated m/z	retention times
Acetyl CoA	Acetyl-CoA	C23H38N7O17P3S	809.1258	50043	C00024	403.5573678	13.87707687
Adipate	Adipic acid	C6H10O4	146.0579	1970	C06104	145.0520342	11.36085954
ADP-ribose	ADP-ribose	C15H23N5O14P2	559.0717	50719	C00301	558.0648944	16.35694961
AMP	AMP	C10H14N5O7P	347.0631	37043	C00020	346.056478	15.01315423
Argininosuccinate	Argininosuccinic acid	C10H18N4O6	290.1226	37046	C03406	291.1303056	13.58560369
Azelate	Azelaic acid	C9H16O4	188.1049	1976	C08261	187.0984972	12.53259786
Butyrate	Butyric acid	C4H8O2	88.0524	26	C00246	87.0469993	14.32069685
Cholate	Cholic acid	C24H40O5	408.2876	36243	C00695	407.2812254	22.54752285
cis-Aconitate	cis-Aconitic acid	C6H6O6	174.0164	37059	C00417	173.0100147	9.537733373
Citraconate	Citraconic acid	C5H6O4	130.0266	2018	C02226	129.0203792	10.76587109
Citramalate	Citramalic acid	C5H8O5	148.0372	51926	C02614	147.0310314	10.70301385
Citrate	Citric acid	C6H8O7	192.027	37071	C00158	191.0206168	9.694615102
CMP	CMP	C9H14N3O8P	323.0519	37072	C00055	322.0459069	14.60144333
Cysteate	Cysteic acid	C3H7NO5S	169.0045	49870	C00506	167.9981728	12.91908212
DCA	Deoxycholic acid	C24H40O4	392.2927	36282	C04483	391.2865339	24.10437947
Dodecanedioate	Dodecanedioic acid	C12H22O4	230.1518	1933	C02678	229.1456585	13.54712723
dTMP	dTMP	C10H15N2O8P	322.0566	37671	C00364	321.0496451	14.63410888
F6P	Fructose 6-phosphate	C6H13O9P	260.029719	38436	C00085	259.0230457	14.16853552
Fumarate	Fumaric acid	C4H4O4	116.011	37095	C00122	115.0051686	9.720723364
G1P	Glucose 1-phosphate	C6H13O9P	260.0297	49864	C00103	259.0226418	13.99673009
G6P	Glucose 6-phosphate	C6H13O9P	260.0297	37776	C00092	259.0232401	14.28433351
Glutarate	Glutaric acid	C5H8O4	132.0423	37356	C00489	131.0361122	10.80346491
Glycerate	Glyceric acid	C3H6O4	106.0266	37097	C00258	105.0202164	13.76586422
Glycolate	Glycolic acid	C2H4O3	76.016	37080	C00160	75.01102306	12.20242449
Isethionate	2-Hydroxyethanesulfonate	C2H6O4S	125.9987	38409	C05123	124.9930287	12.75468103
Isocitrate	Isocitric acid	C6H8O7	192.027	37902	C00311	191.0203597	9.496975539
Lactate	Lactic acid	C3H6O3	90.0317	37125	C00186	89.02599458	13.44158088
Malate	Malic acid	C4H6O5	134.0215	37105	C00711	133.0155257	10.09239897
Malonate	Malonic acid	C3H4O4	104.011	1964	C00383	103.0049726	9.32385843
N-Acetylaspartate	N-Acetylaspartic acid	C6H9NO5	175.0481	37441	C01042	174.0419153	11.4276219
N-Acetylglucosamine 1-phosphate	N-Acetyl-D-glucosamine-1-phosphate	C8H16NO9P	301.0563	37754	C04501	300.0496328	14.66588763
N-Acetylglucosamine 6-phosphate	N-Acetylglucosamine 6-phosphate	C8H16NO9P	301.0563	38205	C00357	300.0497025	15.18363215
N-Acetylglutamate	N-Acetylglutamic acid	C7H11NO5	189.0637	49869	C00624	188.0573847	11.96163698
NAD+	NAD+	C21H28N7O14P2	664.117	71883	C00003	662.1034901	23.95930382
NADP+	NADP+	C21H29N7O17P3	744.0833	67508	C00006	742.0709082	14.84386311
Nicotinate	Nicotinic acid	C6H5NO2	123.032	37821	C00253	122.0259198	14.28713464
O-Phosphoserine	Phosphoserine	C3H8NO6P	185.0089	37174	C01005	184.0034299	12.39345642
Pentanoate	Valeric acid	C5H10O2	102.0681	27	C00803	101.06225	15.07339055
Phenaceturate					C05598	192.0664673	17.04654216
Phthalate	Phthalic acid	C8H6O4	166.0266	38024	C01606	165.0204059	11.22107407
Pimelate	Pimelic acid	C7H12O4	160.0736	1973	C02656	159.0670603	11.78089078
Proline betaine	Proline betaine	C7H13NO2	143.0946	38560	C10172	144.1016974	16.51927334
Propionate	Propionic acid	C3H6O2	74.0368	25	C00163	73.03149049	13.29949225
Ru5P					C00199	229.0119685	13.23072262
S7P	Sedoheptulose 7-phosphate	C7H15O10P	290.0403	50236	C05382	289.0330251	14.56027953
Sebacate	Sebacic acid	C10H18O4	202.1205	1930	C08277	201.1143264	12.86792141
Succinate	Succinic acid	C4H6O4	118.0266	1966	C00042	117.0209658	10.14818667
Taurocholate	Taurocholic acid	C26H45NO7S	515.2917	36987	C05122	514.2856725	23.35428038
UDP	UDP	C9H14N2O12P2	404.0022	37189	C00015	402.9958618	12.7430185
UMP	UMP	C9H13N2O9P	324.0359	37182	C00105	323.0293251	14.31016999
Urate	Uric acid	C5H4N4O3	168.0283	37183	C00366	167.0232932	15.59530285
2,5-Dihydroxybenzoate	Gentisic acid	C7H6O4	154.0266	37104	C00628	153.0214093	14.72108276
2-Hydroxybutyrate	2-Hydroxybutyric acid	C4H8O3	104.0473	1281	C05984	103.0411171	14.43055988
2-Hydroxyglutarate	2-Hydroxyglutaric acid	C5H8O5	148.0372	37369	C02630	147.0310518	10.78880146
2-Isopropylmalate	2-Isopropylmalic acid	C7H12O5	176.0685	2004	C02504	175.0622608	11.74313043
2-Oxoglutarate	Oxoglutaric acid	C5H6O5	146.0215	37135	C00026	145.0147602	10.06297298
3-(4-Hydroxyphenyl)propionate					C01744	165.0570416	16.66050822
3-Methylbutanoate	Isovaleric acid	C5H10O2	102.0681	246	C08262	101.0622534	15.20819689
3PG	3-Phosphoglyceric acid	C3H7O7P	185.9929	51044	C00197	184.9865865	10.30173029
3-Ureidopropionate	Ureidopropionic acid	C4H8N2O3	132.0535	37033	C02642	131.0470753	15.07533894
4-Acetylbutyrate					C02129	129.0561873	15.34222733
5-Oxoproline	Pyroglutamic acid	C5H7NO3	129.0426	37171	C01879	128.0363403	14.75489031
METABOLITES_END
#END